Description
A G-protein biased μ-opioid receptor agonist (Ki= 1 nM in HEK293 cell membranes expressing the mouse receptor); selective for the μ-opioid receptor over the nociceptin receptor and δ- and κ-opioid receptors, as well as a panel of 120 additional receptors, channels, and enzymes at 10 μM; inhibits forskolin-induced cAMP accumulation (EC50 = 0.4 nM), but has limited effects on β-arrestin-2 recruitment (EC50 = 12.6 nM); increases the latency to paw withdrawal in the hot plate test in rats (ED50 = 0.32 mg/kg); exhibits reduced increases in blood peak pCO2 levels compared with morphine at equianalgesic doses in rats
Formal name: (9R)-N-[(3-methoxy-2-thienyl)methyl]-9-(2-pyridinyl)-6-oxaspiro[4.5]decane-9-ethanamine, monohydrochloride
Synonyms:
Molecular weight: 423
CAS: 1401031-39-7
Purity: ≥95%
Formulation: A crystalline solid